Schedule 13G ownership disclosure

NEXUS BIOPHARMA INC

Security class unavailable · CUSIP: 65341U104

Event date: 2016-06-09

Legacy cover-page extraction is best effort and may not include every reporting person.

Filing-level shares
7,899,741
Percent of class
12.3000%

Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.

Source: SEC EDGAR filing

Filing metadata

Accession number
0001078782-16-003011
Form type
SC 13G
Filer
Lau Warren C
CIK
CIK 1293836
Filed
Jun 20, 2016
Reporting period
Jun 09, 2016
Description
Schedule 13G beneficial ownership

Explore SEC Filings Hub